Mecklin Research builds clinical-grade diagnostics, monitoring, and intervention systems — grounded in evidence, designed for scale, and built to work wherever patients actually are.
Seven products, each targeting a specific gap in how diagnostic, therapeutic, and drug development services actually reach patients — from primary health centres to global research organisations.
Continuous 21-day ambulatory ECG with on-device arrhythmia classification across 16,430 AI model parameters — fully local, no cloud dependency. Designed to catch the events a standard 24-hour recording routinely misses.
Unmanned diagnostic kiosk bringing 40+ clinical-grade parameters to pharmacies, rural health posts, and transit hubs. Self-operated, ABDM-linked, and physician-verified within minutes of use.
HIPAA-compliant video consultations with simultaneous ECG, SpO₂, and vitals transmission — giving remote physicians real data alongside the call. Runs on 2G networks, so geography isn't an excuse.
Drug-eluting and bioresorbable coronary stents in cobalt-chromium alloy — engineered for deliverability in complex lesions, with thin-strut architecture to reduce long-term restenosis risk.
Wearable 32-channel EEG for continuous epilepsy monitoring, sleep staging, and neurological event detection — with cloud-based automated seizure annotation and structured neurologist review workflows.
Point-of-care renal function panel integrating eGFR estimation, urinary albumin-to-creatinine ratio, and bioimpedance fluid assessment — enabling early CKD staging at district hospital level without referral delays.
Model-informed drug development (MIDD) services integrating PK/PD modelling, population pharmacokinetics, exposure-response analysis, and quantitative systems pharmacology (QSP) frameworks. Built to support regulatory submissions and reduce risk across clinical development programs for pharmaceutical partners worldwide.
Every color on a Mecklin monitor matches the clinical standard your team already knows. No relearning required when seconds matter.
We own the full stack: sensor, firmware, AI, and clinical validation under one roof. That's not a selling point — it's the only way to move fast without compromising on evidence.
Mecklin Research Private Limited was set up in Lucknow in 2024 on a fairly straightforward premise: the gap between what medicine can do and what patients actually receive is, at its core, an engineering problem. Not an intractable one.
The work spans cardiac monitoring, neurodiagnostics, renal health, quantitative pharmacology, and connected care. That breadth is deliberate — the conditions that carry the heaviest burden globally don't stay within a single specialty, and neither do we.